Literature DB >> 11120436

The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia.

T Wykes1, C Reeder, J Corner.   

Abstract

The current study investigates whether an executive processing measure, response inhibition, is stable over time and across new samples of patients with schizophrenia. Two groups of patients (with and without diagnoses of schizophrenia) were followed up 6 years after baseline data collection. Another separate group of patients with less institutionalized care also completed the same measures to determine whether the response inhibition difficulties had the same prevalence in this new sample.The response inhibition measure was stable over time only in the group of patients with a diagnosis of schizophrenia. The relationship between symptoms and response inhibition difficulties changed over time but was explicable in terms of the interaction between environmental demands and information processing difficulties. The level of response inhibition difficulties (about one-third) was identical in the new sample of patients, which suggests that response inhibition is not dependent on clinical history.

Entities:  

Mesh:

Year:  2000        PMID: 11120436     DOI: 10.1016/s0920-9964(99)00233-9

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  11 in total

1.  Measurement of simple reaction time in antipsychotic treatment of patients with schizophrenia.

Authors:  Blanka Kores Plesnicar; Bojan Zalar; Martina Tomori; Ivan Krajnc
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

2.  Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.

Authors:  Nurith Amitai; Athina Markou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

3.  Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine.

Authors:  David M Thomson; Allan McVie; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2010-09-29       Impact factor: 4.530

4.  Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.

Authors:  Nurith Amitai; Athina Markou
Journal:  Pharmacol Biochem Behav       Date:  2008-09-08       Impact factor: 3.533

Review 5.  Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia.

Authors:  Nurith Amitai; Athina Markou
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

6.  Variable prenatal stress results in impairments of sustained attention and inhibitory response control in a 5-choice serial reaction time task in rats.

Authors:  C A Wilson; R Schade; A V Terry
Journal:  Neuroscience       Date:  2012-05-23       Impact factor: 3.590

7.  Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration.

Authors:  Nurith Amitai; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2008-07-11       Impact factor: 4.530

Review 8.  A review of the effects of modafinil on cognition in schizophrenia.

Authors:  Sharon Morein-Zamir; Danielle C Turner; Barbara J Sahakian
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

9.  Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.

Authors:  Nurith Amitai; Svetlana Semenova; Athina Markou
Journal:  Eur J Pharmacol       Date:  2008-11-09       Impact factor: 4.432

10.  Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.

Authors:  Nurith Amitai; Svetlana Semenova; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2007-05-12       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.